BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poonaki E, Ariakia F, Jalili-nik M, Shafiee Ardestani M, Tondro G, Samini F, Ghasemi S, Sahab-negah S, Gorji A. Targeting BMI-1 with PLGA–PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells. Cancer Nano 2021;12. [DOI: 10.1186/s12645-021-00078-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sabu A, Liu TI, Ng SS, Doong RA, Huang YF, Chiu HC. Nanomedicines Targeting Glioma Stem Cells. ACS Appl Mater Interfaces 2023;15:158-81. [PMID: 35544684 DOI: 10.1021/acsami.2c03538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Poonaki E, Kahlert UD, Meuth SG, Gorji A. The role of the ZEB1–neuroinflammation axis in CNS disorders. J Neuroinflammation 2022;19:275. [DOI: 10.1186/s12974-022-02636-2] [Reference Citation Analysis]
3 Eidizade F, Soukhtanloo M, Zhiani R, Mehrzad J, Mirzavi F. Inhibition of glioblastoma proliferation, invasion, and migration by Urolithin B through inducing G0 / G1 arrest and targeting MMP ‐2/‐9 expression and activity. BioFactors 2022. [DOI: 10.1002/biof.1915] [Reference Citation Analysis]
4 Poonaki E, Nickel AC, Shafiee Ardestani M, Rademacher L, Kaul M, Apartsin E, Meuth SG, Gorji A, Janiak C, Kahlert UD. CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells. Int J Mol Sci 2022;23:5479. [PMID: 35628289 DOI: 10.3390/ijms23105479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]